Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AlphaClone International ETF (ALFI)

Delayed Data
As of Nov 23
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the total return performance, before fees and expenses, of the AlphaClone International Downside Hedged Index (the "index"). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index. The index utilizes a proprietary, quantitative Clone Score methodology developed by the fund's investment adviser, to replicate the foreign equity securities trading in the U.S. through American Depositary Receipts ("ADRs") favored as investments by hedge funds and institutional investors. The fund is non-diversified.

No recent news for AlphaClone International ETF.


1 month-- 3 years--
3 months-- 5 years--
1 year-- Since inception--
Data through --

Quote Details

Previous close$20.24
Open day’s range-- – --
Net asset value (NAV)-- (--)
Daily volume2
Average volume (3 months)--
Data as of 11/23/2015

Peer Comparisonvs. Long/short equity ETFs

Performance 5-yr return--+4.81%
Expense Gross exp ratio0.95%0.89%
Risk 5 year sharpe ratio--0.70
Net assets--$66.9M
Average market cap$28.3B$38.4B
Average P/E12.316.7
Dividend / Share--0.13%


No competitors data available.


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
BIDU Baidu15.87%
QUNR Qunar Cayman Islands Ltd5.21%
SHPG Shire5.14%
TEVA Teva Pharmaceutical5.14%
JD JD.com4.69%
BUD Anheuser-Busch InBev4.18%
HDB HDFC Bank Ltd3.83%
EDU New Oriental Education & Technology Group Inc3.82%
TSM Taiwan Semiconductor3.20%
GSK GlaxoSmithKline2.80%